July 2019
Volume 60, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2019
In vitro bio-functional profiles and in vivo outcome of α1,3-galactosyltransferase gene-knockout miniature pig-to-nonhuman primate corneal xenotransplantation
Author Affiliations & Notes
  • Mee Kum Kim
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Democratic People's Republic of)
    Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Korea (the Republic of)
  • Chang Ho Yoon
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Democratic People's Republic of)
    Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Korea (the Republic of)
  • Se Hyun Choi
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Democratic People's Republic of)
    Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Korea (the Republic of)
  • Hyun Ju Lee
    Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Korea (the Republic of)
  • Hee Jung Kang
    Department of Laboratory Medicine, Hallym University College of Medicine, Korea (the Republic of)
  • Jong Min Kim
    Translational Xenotransplantation Research Center, Seoul National University College of Medicine, Korea (the Republic of)
  • Chung-Gyu Park
    Translational Xenotransplantation Research Center, Seoul National University College of Medicine, Korea (the Republic of)
  • Kimyung Choi
    Optipharm, Inc., Korea (the Republic of)
  • Hyunil Kim
    Optipharm, Inc., Korea (the Republic of)
  • Curie Ahn
    Department of Internal medicine, Seoul National University College of Medicine, Korea (the Republic of)
  • Hyuk Jin Choi
    Ophthalmology, Seoul National University College of Medicine, Seoul, Korea (the Democratic People's Republic of)
    Laboratory of Ocular Regenerative Medicine and Immunology, Seoul Artificial Eye Center, Seoul National University Hospital Biomedical Research Institute, Korea (the Republic of)
  • Footnotes
    Commercial Relationships   Mee Kum Kim, None; Chang Ho Yoon, None; Se Hyun Choi, None; Hyun Ju Lee, None; Hee Jung Kang, None; Jong Min Kim, None; Chung-Gyu Park, None; Kimyung Choi, None; Hyunil Kim, None; Curie Ahn, None; Hyuk Jin Choi, None
  • Footnotes
    Support  Study was supported by a grant from the Korea Healthcare Technology R&D Project, Ministry for Health & Welfare (Project No. HI13C0954).
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6312. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Mee Kum Kim, Chang Ho Yoon, Se Hyun Choi, Hyun Ju Lee, Hee Jung Kang, Jong Min Kim, Chung-Gyu Park, Kimyung Choi, Hyunil Kim, Curie Ahn, Hyuk Jin Choi; In vitro bio-functional profiles and in vivo outcome of α1,3-galactosyltransferase gene-knockout miniature pig-to-nonhuman primate corneal xenotransplantation. Invest. Ophthalmol. Vis. Sci. 2019;60(9):6312.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To investigate bio-functional corneal profiles and outcome of α1,3-galactosyltransferase gene-knockout miniature (GTKOm) pig-to-nonhuman primate (NHP) corneal xenotransplantation.

Methods : We used 14 eyes from 3 types of 7 GTKO pigs (GTKOm, n = 4; GTKO/hCD39 knock-in miniature (KIm), n = 2; and GTKO/CMAH/iGB3s triple KO miniature (TKOm), n = 1). For in vitro study, endothelial cell density (ECD) changes and Na-and K-dependent ATPase after 7 days of preservation were evaluated. Endothelial cell proliferation was also measured. For in vivo study, 9 rhesus macaques underwent full thickness corneal xenotransplantation. Four were transplanted 2 GTKOm and 2 TKOm pig corneas and administered full dose immunosuppression (full dose group) including anti-CD20 antibody (Ab), tacrolimus, and basiliximab, which had already showed long-term graft survival in wild type miniature pig cornea. The other five were transplanted 4 GTKOm and 1 GTKO/hCD39 KIm pig corneas and administered low dose immunosuppression including tacrolimus and basiliximab (without anti-CD20 Ab). Changes in T and B cell subsets, anti-αGal, and non-αGal Abs and C3a were evaluated.

Results : ECD of all corneas maintained at more than > 2800/mm2 through 7 days. ATPase pumps were well stained. Doubling time was 30.41 hours. Full dose group showed long-term graft survival (>277, >187, >187, >83 days). However, median graft survival of low dose group was 72 days (165, 91, 72, 55, 37 days) (Figure 1). T cell subsets were not changed in both groups and were not different from each other. Activated B cells in high dose group at last examination were lower than that in low dose group (P = 0.026). Anti-αGal Abs were not changed in both groups. At 4 weeks and last examination, anti-non-αGal IgG was increased from baseline (all P = 0.043) in low dose group, but not changed in high dose group. Aqueous C3a concentration at last examination in low dose group was increased from baseline (P = 0.043), and was higher than that in high dose group (P = 0.014).

Conclusions : Profiles of GTKOm pig cornea is feasible for corneal xenotransplantation. It is still important to inhibition of B cells and complement activations as well as T cell suppression even using GTKOm and/or hCD39 KI pig corneas in pig-to-NHP corneal xenotransplantation.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

 

Representative photographs of corneal grafts after transplantation.

Representative photographs of corneal grafts after transplantation.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×